Please ensure Javascript is enabled for purposes of website accessibility

5 Best Health Insurance Stocks to Buy Right Now

By Keith Speights – Oct 15, 2016 at 6:02AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With consolidation and Obamacare uncertainty in the air, here are the top health insurance stocks on the market.

Image source: Getty Images.

Health insurance stocks provide investors a stake in an integral part of the rapidly growing healthcare industry, and can make a great addition to you portfolio. Here are the five best health insurance stocks to buy right now. 

Company Share Price Market Cap Dividend Yield P/E (ttm) YTD Return
Aetna (AET) $114.71 $40.2B 0.88% 16.8 6.1%
Anthem (ELV 2.33%) $124.80 $32.8B 2.13% 14.4 (10.5%)
Centene (CNC 2.35%) $63.08 $10.77B N/A 24.4  (4.1%)
UnitedHealth Group (UNH 1.29%) $138.08 $131.5B 1.83% 21.6 17.4%
Wellcare Health Plans (WCG) $119.81 $5.3B N/A 29.9 53.2%

Data source: Yahoo! Finance. P/E=Price/Earnings. ttm=Trailing 12 Month. YTD=Year to Date. All data as of Oct. 10, 2016.

Merger and acquisition fever

Two of the health insurers on our list are in the midst of major acquisitions. Aetna hopes to buy Humana (HUM 2.25%), while Anthem is attempting to acquire Cigna (CI). Both acquisitions are being undertaken for similar reasons -- and both are being opposed by the U.S. government for similar reasons.

Aetna sees Humana's Medicare-focused business as being complementary with its own primarily commercially focused model. By combining the two, Aetna says it expects it would be able to offer customers across the U.S. more choices at more affordable prices.

Anthem's reasons for wanting to buy Cigna echo that theme. While Anthem has pointed out the value that would be created for shareholders with the acquisition, the company has also asserted that it would be able to offer broader choices and more affordable plans if combined with Cigna.

The Department of Justice is trying to stop both deals, though. Instead of giving customers more choices at better prices, the government has concluded these megamergers will reduce competition and increase prices.

These potential deals are having a ripple impact on other health insurers on our list. If the Anthem-Cigna transaction goes through, UnitedHealth will be knocked out of its current status as the largest health insurer in the country. UnitedHealth is in acquisition mode itself, after announcing plans to buy regional health insurer Rocky Mountain Health in July.

Centene and Wellcare could also be affected by a Cigna sale: Both have made offers to buy some of the Medicare Advantage plans that Aetna would be required to sell to mitigate antitrust concerns. 

Obamacare turmoil

At the same time as health insurers are consolidating, many are also fleeing from the Obamacare exchanges. Why? They're losing a lot of money from participating in them.

UnitedHealth Group plans to pull out of Obamacare exchanges in at least 16 states. The insurer's Obamacare losses totaled over $1 billion over the past two years. CEO Stephen Hemsley stated that his company would have no "meaningful" financial exposure to the exchanges in 2017.

Similarly, Aetna announced in August that it planned to withdraw from 11 of the 15 state exchanges where it currently operates. Aetna's losses related to the Obamacare exchanges haven't been as massive as UnitedHealth's, but the company has still lost $430 million since the beginning of 2014.

While Anthem has also lost money on the exchanges, the company remains one of the few major health insurers committed to continued participation in them. Anthem is even offering to expand its presence to nine additional exchanges if the government allows the Cigna acquisition to go through.

Meanwhile, Centene and Wellcare have thrived under Obamacare. The smaller health insurers primarily focus on Medicare and Medicaid patients, and both benefited tremendously from the Obamacare Medicaid expansion. Centene and Wellcare also were able to use their Medicaid expertise to build Obamacare exchange plans that were attractive to lower-income customers who receive the highest federal subsidies. 

Making the list

These companies made the list of best health insurance stocks to buy for several reasons. One is that all of them are positioned to come out in great shape when the dust settles from the current questions about acquisitions and Obamacare. 

All five companies should also experience solid growth in the future. Wall Street projects double-digit percentage annual earnings growth for each of these health insurers over the next five years.

Aetna, Anthem, and UnitedHealth Group made the cut largely because their economies of scale and marketing power give them huge competitive advantages. If Aetna and Anthem make it past antitrust scrutiny, those advantages will increase. All three big insurers should be able to survive and thrive no matter what is thrown their way. 

Centene and Wellcare aren't nearly as big, but their focus on the Medicare and Medicaid niche markets give them competitive advantages as well. I wouldn't be surprised if either or both of these companies are acquisition targets themselves at some point in the future.

If I had to only pick one of these health insurance stocks, I'd go with Centene. It has tremendous growth prospects -- higher than any of the big insurers. Wellcare's nice run in 2016 has driven up its valuation, but Centene's share price still looks attractive, especially factoring in the earnings growth the company should see. 

Keith Speights has no position in any stocks mentioned. The Motley Fool recommends Anthem and UnitedHealth Group. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.